我们也知道有些初始应答较慢的患者,没有获得快速病毒学应答,但可能在12,16或24周时病毒检测阴性,对于这些患者延长治疗可能会有好处。
We know that slower initial responders, those that don't have a rapid viral response, but maybe become negative by week 12, 16, or 24, that extending therapy may also be of some benefit.
我们也知道有些初始应答较慢的患者,没有获得快速病毒学应答,但可能在12,16或24周时病毒检测阴性,对于这些患者延长治疗可能会有好处。
We know that slower initial responders, those that don't have a rapid viral response, but maybe become negative by week 12, 16, or 24, that extending therapy may also be of some benefit.
应用推荐